• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 10623
Device Problems Difficult to Advance (2920); Material Deformation (2976)
Patient Problems No Consequences Or Impact To Patient (2199); No Known Impact Or Consequence To Patient (2692)
Event Date 10/28/2020
Event Type  malfunction  
Manufacturer Narrative
Initial reporter address 1: (b)(6).
 
Event Description
It was reported that stent damage occurred.The angulated target lesion was located in the moderately tortuous and severely calcified right coronary artery.A 3.50 x 38 synergy drug-eluting stent was advanced but resistance was encountered.When the device was removed, it was noted that the edge of the stent was damaged.No known patient complications nor injuries reported.
 
Event Description
It was reported that stent damage occurred.The angulated target lesion was located in the moderately tortuous and severely calcified right coronary artery.A 3.50 x 38 synergy drug-eluting stent was advanced but resistance was encountered.When the device was removed, it was noted that the edge of the stent was damaged.No known patient complications nor injuries reported.
 
Manufacturer Narrative
E1 initial reporter address 1: (b)(6).Device evaluated by mfr.: synergy ous mr 3.50 x 38 mm stent delivery system was returned for analysis.A visual examination of the stent found that the stent struts at the distal stent strut row were damaged with struts pulled proximally.The undamaged crimped stent outer diameter measured and the result was within maximum crimped stent profile measurement.Stent damage most likely occurred when the stent met resistance of a calcified lesion, the stent struts got caught in the calcification.The balloon cones were reviewed, and no issues were noted.Balloon cones shows signs of positive pressure having been applied.A visual and microscopic examination of the tip showed no signs of damage.A visual and tactile examination of the hypotube found multiple kinks on several locations of the hypotube shaft.This type of damage is consistent with excessive force that could have been applied to the delivery system.A visual and tactile examination of the outer and mid-shaft section and a visual examination of the inner lumen found no issues with the extrusion shaft.A recommended 0.014 inch test guidewire was loaded successfully.No other issues were identified during the product analysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key10848240
MDR Text Key216940762
Report Number2134265-2020-15822
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 12/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/16/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/11/2021
Device Model Number10623
Device Catalogue Number10623
Device Lot Number0024672193
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/25/2020
Date Manufacturer Received12/11/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-